RBM10 and lung carcinoma: RBM10 LOF has been shown to promote lung cancer development and TKI resistance.[49] Based on our results, it is conceivable that the increased RAC1B splicing resulting from RBM10 LOF is partially responsible for the RBM10‐mediated phenotypes in LUAD, aside from the reported mechanisms.[50]